Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI

NCT02859727 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
37
Enrollment
INDUSTRY
Sponsor class

Stopped All participant have transitioned to commercial product or compassionate use.

Conditions

Interventions

Sponsor

Pharming Technologies B.V.